These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10995915)

  • 1. Pharmacokinetic study of intraarterial local intestinal infusion of tacrolimus.
    Alessiani M; Regazzi M; Abbiati F; Ferrari P; Molinaro M; Iacona I; Klersy C; Viezzoli A; Fayer F; Pileggi A; Zitelli E; Burroni B; Scandone M; Dionigi P; Zonta A
    Transplant Proc; 2000 Sep; 32(6):1214-5. PubMed ID: 10995915
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomal tacrolimus and intestinal drug concentration.
    Dutta S; Mezei M; Lee TD; McAlister VC
    Transplant Proc; 1998 Sep; 30(6):2651-2. PubMed ID: 9745533
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between FK 506 and diltiazem in an animal model.
    Regazzi MB; Iacona I; Alessiani M; Spada M; Vaccarisi S; Villani P; Molinaro M
    Transplant Proc; 1996 Apr; 28(2):1017-8. PubMed ID: 8623215
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioequivalence of a new strength tacrolimus capsule under development.
    Bekersky I; Dressler D; Boswell GW; Fergen B; Tracewell W; Mekki Q
    Transplant Proc; 1998 Jun; 30(4):1457-9. PubMed ID: 9636591
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic characteristics of two types of liposomal FK 506.
    Yagura K; Nakajima Y; Ko S; Kanehiro H; Nakano H
    Transplant Proc; 1996 Jun; 28(3):1390-1. PubMed ID: 8658708
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a macromolecular prodrug of FK 506: III: In vivo disposition of FK 506-dextran conjugate.
    Yoshimura N; Yura H; Hamashima T; Oka T; Takakura Y; Hadhida M
    Transplant Proc; 1998 Jun; 30(4):1029-30. PubMed ID: 9636415
    [No Abstract]   [Full Text] [Related]  

  • 7. Trough levels of tacrolimus.
    Stolk LM; Van Duijnhoven EM; Christiaans MH; van Hooff JP
    Ther Drug Monit; 2002 Aug; 24(4):573; author reply 573-4. PubMed ID: 12142646
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation.
    Regazzi MB; Alessiani M; Reggiani P; Gatti S; Spada M; Iacona I; Rossi G; Tzakis A
    Transplant Proc; 1997 May; 29(3):1857-60. PubMed ID: 9142302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tacrolimus hydrate (tacrolimus)].
    Matsuda J
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():465-8. PubMed ID: 15658364
    [No Abstract]   [Full Text] [Related]  

  • 10. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing the right dose of new immunossuppressive drugs for new populations: importance of pharmacokinetic studies.
    Felipe CR; Garcia C; Moreira S; Olsen N; Silva HT; Pestana OM
    Transplant Proc; 2001; 33(1-2):1095-6. PubMed ID: 11267207
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome.
    Hou Q; Han W; Fu X
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1861-2. PubMed ID: 23765408
    [No Abstract]   [Full Text] [Related]  

  • 13. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
    Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
    Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].
    Xue L; Rui JZ; Zhang Y; Miao LY
    Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.
    Antignac M; Hulot JS; Boleslawski E; Hannoun L; Touitou Y; Farinotti R; Lechat P; Urien S
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):409-16. PubMed ID: 15991041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.
    Undre NA; Schäfer A
    Transplant Proc; 1998 Jun; 30(4):1261-3. PubMed ID: 9636512
    [No Abstract]   [Full Text] [Related]  

  • 18. The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.
    Prytuła AA; Cransberg K; Bouts AH; van Schaik RH; de Jong H; de Wildt SN; Mathôt RA
    Clin Pharmacokinet; 2016 Sep; 55(9):1129-43. PubMed ID: 27138785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of FK 506 in living-related liver transplantation.
    Satomura K; Ozaki N; Okajima H; Egawa H; Uemoto S; Inomata Y; Tanaka K; Yamaoka Y; Hashida T; Yasuhara M; Inui K
    Transplant Proc; 1996 Apr; 28(2):1005. PubMed ID: 8623209
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus.
    Cantarovich M; Fridell J; Barkun J; Metrakos P; Besner JG; Deschênes M; Alpert E; Aalamian Z; Tchervenkov JI
    Transplant Proc; 1998 Jun; 30(4):1460-1. PubMed ID: 9636592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.